Jennifer Bacik

9.9k total citations · 4 hit papers
43 papers, 7.4k citations indexed

About

Jennifer Bacik is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Jennifer Bacik has authored 43 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 23 papers in Surgery and 12 papers in Molecular Biology. Recurrent topics in Jennifer Bacik's work include Testicular diseases and treatments (19 papers), Renal cell carcinoma treatment (18 papers) and Ovarian cancer diagnosis and treatment (9 papers). Jennifer Bacik is often cited by papers focused on Testicular diseases and treatments (19 papers), Renal cell carcinoma treatment (18 papers) and Ovarian cancer diagnosis and treatment (9 papers). Jennifer Bacik collaborates with scholars based in United States, Germany and United Kingdom. Jennifer Bacik's co-authors include Robert J. Motzer, Madhu Mazumdar, Paul Russo, William J. Berg, Barbara A. Murphy, Alison Amsterdam, Joseph M. Ferrara, Victor E. Reuter, Dean F. Bajorin and George J. Bosl and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Cancer.

In The Last Decade

Jennifer Bacik

43 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma

1999 1.4k citations Robert J. Motzer, Madhu Mazumdar et al. Journal of Clinical Oncology profile →
Interferon-Alfa as a Comparative Treatment for Clinical Trials of New Therapies Against Advanced Renal Cell Carcinoma

2002 1.2k citations Robert J. Motzer, Jennifer Bacik et al. Journal of Clinical Oncology profile →
Sunitinib in Patients With Metastatic Renal Cell Carcinoma

2006 969 citations Robert J. Motzer, Brian I. Rini et al. JAMA profile →
Prognostic Factors for Survival in Previously Treated Patients With Metastatic Renal Cell Carcinoma

2004 609 citations Robert J. Motzer, Jennifer Bacik et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Jennifer Bacik

Since Specialization

Citations

This map shows the geographic impact of Jennifer Bacik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Bacik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Bacik more than expected).

Fields of papers citing papers by Jennifer Bacik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Bacik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Bacik. The network helps show where Jennifer Bacik may publish in the future.

Co-authorship network of co-authors of Jennifer Bacik

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Bacik. A scholar is included among the top collaborators of Jennifer Bacik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Bacik. Jennifer Bacik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase II trial of lenalidomide in patients with metastatic renal cell carcinoma 2007 ·Investigational New Drugs ·Premal H. Patel, G. Varuni Kondagunta, Lawrence H. Schwartz, Nicole Ishill, Jennifer Bacik, John DeLuca, Paul Russo, Robert J. Motzer	16
2	A phase II trial of 17-(Allylamino)-17-demethoxygeldanamycin in patients with papillary and clear cell renal cell carcinoma 2006 ·Investigational New Drugs ·Ellen A. Ronnen, G. Varuni Kondagunta, Nicole Ishill, (unknown), John DeLuca, Lawrence H. Schwartz, Jennifer Bacik, Robert J. Motzer	125
3	A brief symptom index for advanced renal cell carcinoma 2006 ·Health and Quality of Life Outcomes ·David T. Eton, David Cella, Jennifer Bacik, Robert J. Motzer	10
4	Treatment outcome for metastatic papillary renal cell carcinoma patients 2006 ·Cancer ·Ellen A. Ronnen, G. Varuni Kondagunta, Nicole Ishill, (unknown), Paul Russo, Victor E. Reuter, Jennifer Bacik, Robert J. Motzer	68
5	Sunitinib in Patients With Metastatic Renal Cell Carcinoma breakdown → 2006 ·JAMA ·Robert J. Motzer, Brian I. Rini, Ronald M. Bukowski, Brendan D. Curti, Daniel J. George, Gary R. Hudes, Bruce G. Redman, Kim Margolin, Jaime R. Merchan, George Wilding, Michelle S. Ginsberg, Jennifer Bacik, Sindy T. Kim, Charles M. Baum, M. Dror Michaelson	969
6	Presentation and subsequent publication rates of phase I oncology clinical trials 2005 ·Cancer ·Luis H. Camacho, Jennifer Bacik, Alexander Cheung, David R. Spriggs	42
7	Sequential dose-intensive paclitaxel plus ifosfamide and carboplatin plus etoposide with autologous stem cell transplantation for germ cell tumor (GCT) patients (pts) 2005 ·Journal of Clinical Oncology ·G. Varuni Kondagunta, Jennifer Bacik, Dean F. Bajorin, Lillian Reich, Joel Sheinfeld, Manjit S. Bains, George J. Bosl, Robert J. Motzer	5
8	Incidence of Late-Relapse Germ Cell Tumor and Outcome to Salvage Chemotherapy 2005 ·Journal of Clinical Oncology ·Ellen A. Ronnen, G. Varuni Kondagunta, Jennifer Bacik, Stéphanie Marion, Dean F. Bajorin, Joel Sheinfeld, George J. Bosl, Robert J. Motzer	49
9	The Development of a Validated Instrument to Evaluate Bowel Function After Sphincter-Preserving Surgery for Rectal Cancer 2005 ·Diseases of the Colon & Rectum ·Larissa K. Temple, Jennifer Bacik, (unknown), Lester Gottesman, Philip B. Paty, Martin R. Weiser, José G. Guillem, Bruce D. Minsky, (unknown), Howard T. Thaler, Deborah Schrag, Douglas W. Wong	224
10	Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors. 2004 ·Molecular Cancer ·Sanjay Koul, James M. McKiernan, Gopeshwar Narayan, Jane Houldsworth, Jennifer Bacik, (unknown), Adel Assaad, Mahesh Mansukhani, Victor E. Reuter, George J. Bosl, R. S. K. Chaganti, Vundavalli V. Murty	116
11	Phase II Trial of Temozolomide in Patients with Cisplatin-Refractory Germ Cell Tumors 2004 ·Investigational New Drugs ·G. Varuni Kondagunta, Jennifer Bacik, Lawrence Schwartz, Joel Sheinfeld, Dean F. Bajorin, Jacqueline Vuky, Stéphanie Marion, Madhu Mazumdar, George J. Bosl, Robert J. Motzer	9
12	The functional assessment of cancer therapy–BRM (FACT–BRM): A new tool for the assessment of quality of life in patients treated with biologic response modifiers 2004 ·Quality of Life Research ·Jennifer Bacik, Madhu Mazumdar, Barbara A. Murphy, Diane L. Fairclough, Sonya Eremenco, Tania Mariani, Robert J. Motzer, David Cella	33
13	Prognostic Factors for Survival in Previously Treated Patients With Metastatic Renal Cell Carcinoma breakdown → 2004 ·Journal of Clinical Oncology ·Robert J. Motzer, Jennifer Bacik, Lawrence H. Schwartz, Victor E. Reuter, Paul Russo, Stéphanie Marion, Madhu Mazumdar	609
14	Methods for categorizing a prognostic variable in a multivariable setting 2003 ·Statistics in Medicine ·Madhu Mazumdar, Alex Smith, Jennifer Bacik	94
15	Phase II trial of ZD1839 (IRESSA™) in patients with advanced renal cell carcinoma 2003 ·Investigational New Drugs ·(unknown), Jennifer Bacik, Michelle S. Ginsberg, Stéphanie Marion, Paul Russo, Madhu Mazumdar, Robert J. Motzer	71
16	Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcome 2003 ·Urology ·James M. McKiernan, Robert J. Motzer, Dean F. Bajorin, Jennifer Bacik, George J. Bosl, Joel Sheinfeld	66
17	Interferon-Alfa as a Comparative Treatment for Clinical Trials of New Therapies Against Advanced Renal Cell Carcinoma breakdown → 2002 ·Journal of Clinical Oncology ·Robert J. Motzer, Jennifer Bacik, Barbara A. Murphy, Paul Russo, Madhu Mazumdar	1184
18	Testicular Seminoma: A Clinicopathologic and Immunohistochemical Study of 105 Cases with Special Reference to Seminomas with Atypical Features 2002 ·International Journal of Surgical Pathology ·Satish K. Tickoo, Brian Hutchinson, Jennifer Bacik, Madhu Mazumdar, Robert J. Motzer, Dean F. Bajorin, George J. Bosl, Victor E. Reuter	57
19	Role of Postchemotherapy Adjunctive Surgery in the Management of Patients With Nonseminoma Arising From the Mediastinum 2001 ·Journal of Clinical Oncology ·Jacqueline Vuky, Manjit S. Bains, Jennifer Bacik, Geralyn Higgins, Dean F. Bajorin, Madhu Mazumdar, George J. Bosl, Robert J. Motzer	63
20	Effect of Cytokine Therapy on Survival for Patients With Advanced Renal Cell Carcinoma 2000 ·Journal of Clinical Oncology ·Robert J. Motzer, Madhu Mazumdar, Jennifer Bacik, Paul Russo, William J. Berg, (unknown)	164

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact